Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 273 - 280 of 11617 results
What Should 401k Plan Sponsors Do Now That the Fiduciary Rule Has Been Stayed?
July 30, 2024| News
A Public Health Call to Arms: The Long Road to FDA’s Misinformation Guidance
July 30, 2024| News
Energy & Sustainability Washington Update – August 2024
July 29, 2024| Blog| Viewpoint
Telephone and Texting Compliance News: Litigation Update — TCPA Defense Post-Chevron: Insights from Cacho v. McCarthy & Kelly LLC
July 29, 2024| Article| Viewpoint
FDA Issues Guidance Intended to Diversify and Enhance Clinical Trial Participation
July 29, 2024| Blog| Viewpoint
Telephone and Texting Compliance News — July 2024
July 29, 2024| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.